Nanotechnology: Improving clinical testing?

Clinical Chemistry

Volumn 56, Issue 9, 2010, Pages 1384-1389

  Fortina, Paolo ^a   Kricka, Larry J ^b   Bonnell, Dawn ^c   Kulkarni, Amit ^d   Wang, Joseph ^e   Miyahara, Yuri ^f   Ure, David ^g  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d GENERAL ELECTRIC COMPANY   (United States)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^f NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

^g Inanovate Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; QUANTUM DOT;

CANCER THERAPY; DNA DETERMINATION; DNA SEQUENCE; DRUG DELIVERY SYSTEM; HEMODYNAMIC PARAMETERS; HUMAN; NANOANALYSIS; NANOIMAGING; NANOTECHNOLOGY; NOTE; PROTEIN ANALYSIS;

CLINICAL CHEMISTRY TESTS; HUMANS; LAB-ON-A-CHIP DEVICES; NANOSTRUCTURES; NANOTECHNOLOGY;

EID: 77956384501     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.138750     Document Type: Note

References (5)

1. Kommareddy S, Amiji M. Biodistribution and pharmacokinetic analysis of long-circulating thiolated gelatin nanoparticles following systemic administration in breast cancer-bearing mice. J Pharm Sci 2007;96:397-407. (Pubitemid 46363569)
2. Wang J, Sui M, Fan W. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Curr Drug Metab 2010;11:129-41.
3. Agasti SS, Rana S, Park MH, Kim CK, You CC, Rotello VM. Nanoparticles for detection and diagnosis. Adv Drug Deliv Rev 2010;62: 316-28.
4. Gu LQ, Shim JW. Single molecule sensing by nanopores and nanopore devices. Analyst 2010;135: 441-51.
5. Wang J. Nanomaterial-based amplified transduction of biomolecular interactions. Small 2005;1: 1036-43. (Pubitemid 43951670)